Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov record for the sotatercept PAH study shows no apparent updates.SummaryDifference0.0%

- Check9 days agoChange DetectedThe study record for the sotatercept HYPERION trial is displayed, with its terminated status and study design, eligibility, locations, and outcome measures. It also includes record history, publications, and links to study documents and data-sharing information.SummaryDifference100%

- Check16 days agoChange DetectedThe site revision changed from v3.7.2 to v3.8.0. The study page remains inaccessible and displays a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide banner announces NIH website updates and says the term “Super Intelligence” is being used in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error instead of study details.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.